Alteration of the sexual response cycle in women using combined oral contraceptives.
Objective: To estimate the effect of female sexuality due to the use of the contraceptive combination estradiol valerate /Dienogest against Ethinylestradiol /Drospirenone. Material and methods: A controlled, randomized, unblinded clinical trial was carried out on 174 women, between 18 and 39 years o...
| Publicado en: | Salud Uninorte Vol. 34; no. 2; pp. 430 - 443 |
|---|---|
| Autores principales: | , |
| Formato: | Artículo |
| Publicado: |
Fundacion Universidad del Norte
mai-ago2018
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=134901766&site=ehost-live header: @attributes: shortDbName: lth uiTerm: 134901766 longDbName: MedicLatina uiTag: AN controlInfo: bkinfo: jinfo: jid: 01205552 78FH jtl: Salud Uninorte issn: 01205552 maglogo: N pubinfo: dt: mai-ago2018 vid: 34 iid: 2 pid: 15491 pub: Fundacion Universidad del Norte artinfo: ui: 134901766 ppf: 430 ppct: 13 formats: fmt: @attributes: type: P size: 526KB tig: atl: Alteration of the sexual response cycle in women using combined oral contraceptives. aug: au: De La Hoz, Franklin José Espitia Orozco Gallego, Hoover affil: Gynecology and Obstetrics, Universidad Militar Nueva Granada. Uroginecology /FUCS - Hospital San José /Unicamp, Brazil Clinical Sexology Master in sexology: education and sexual counseling. University de Alcalá de Henares. Gynecology Service and Maternal Fetal Medicine, Clinica La Sagrada Familia, Armenia, Quindío, Colombia Licenciatura En Física y Matemáticas, Maestría/Magister En Física, Universidad Tecnológica de Pereira - UTP su: Menstrual cycle Contraceptives Estradiol Oral contraceptives Sexual cycle Women's sexual behavior Androgens Armenia sug: subj: Armenia Menstrual cycle Contraceptives Estradiol Oral contraceptives Sexual cycle Women's sexual behavior Androgens keyword: Contraceptive Agents Sexuality Testosterone Women Andrógenos Anticonceptivos Mujeres Sexualidad Testosterona ab: Objective: To estimate the effect of female sexuality due to the use of the contraceptive combination estradiol valerate /Dienogest against Ethinylestradiol /Drospirenone. Material and methods: A controlled, randomized, unblinded clinical trial was carried out on 174 women, between 18 and 39 years of age, who underwent two hormonal contraceptive options with estradiol valerate /Dienogest and ethinylestradiol /Drospirenone; in a private clinic in Armenia, Quindío, between 2013 and 2017. The female sexual function index (IFSF) was used to analyze the sexual function of the participating women; at the beginning, at six, at eighteen and thirty-six months after the start of the contraceptive. Results: At the end of the study, the contraceptive combination estradiol valerate /Dienogest was a less aggressive therapy in the alteration of the sexual response cycle of the users, while the ethinylestradiol /drospirenone combination significantly affects the desire and excitement with lower scores in the IFSF. Conclusions: The results indicate that the estradiol valerate /Dienogest combination affects the desire, arousal and IFSF score less than the ethinylestradiol /drospirenone combination. Objectivo: Estimar la afectación de la sexualidad femenina por el uso de la combinación anticonceptiva Valerato de estradiol/Dienogest frente a Etinilestradiol/Drospirenona. Material y métodos: Se realizó un ensayo clínico controlado, aleatorizado, no cegado en 174 mujeres, entre 18 y 39 años, sometidas a dos opciones de anticoncepción hormonal con Valerato de estradiol/Dienogest y Etinilestradiol/Drospirenona; en una clínica privada de Armenia, Quindío, entre 2013 y 2017. Se utilizó el índice de función sexual femenina (IFSF) para analizar la función sexual de las mujeres participantes; al comienzo, a los seis, a los dieciocho y treinta y seis meses de iniciado el anticonceptivo. Resultados: Al finalizar el estudio resultó la combinación anticonceptiva Valerato de estradiol/Dienogest una terapia menos agresiva en la alteración del ciclo de la respuesta sexual de las usuarias, mientras que la combinación Etinilestradiol/Drospirenona afecta de forma significativa el deseo y la excitación con menores puntajes en el IFSF. Conclusiones: Los resultados indican que la combinación Valerato de estradiol/Dienogest afecta menos el deseo, la excitación y la puntuación del IFSF que la combinación Etinilestradiol/Drospirenona. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y custom: Copyright of Salud Uninorte is the property of Fundacion Universidad del Norte and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. item: Salud Uninorte holder: Fundacion Universidad del Norte dt: @attributes: year: 2018 holdings: @attributes: islocal: N |
|---|